Bruno Strigini
About Bruno Strigini
Bruno Strigini is a seasoned healthcare executive with over 30 years of global experience. He currently holds director positions at several companies, including Kos, Neuraxpharm, and Kedrion Biopharma, and has previously served as CEO of Novartis Oncology.
Current Role at Kos
Bruno Strigini has been serving as Director at Kos since 2023. His role involves overseeing various strategic initiatives within the organization. Kos operates in the healthcare sector, focusing on innovative solutions to improve patient outcomes. Strigini's extensive background in the industry contributes to the company's objectives in California, United States.
Previous Experience at Novartis Oncology
Bruno Strigini held the position of Chief Executive Officer at Novartis Oncology from 2014 to 2018. During his tenure in the Greater New York City Area, he was responsible for leading the company's oncology division, focusing on the development and commercialization of cancer therapies. His leadership contributed to the company's growth and strategic direction in the competitive oncology market.
Educational Background in Pharmaceutical Sciences
Bruno Strigini studied Pharmaceutical Sciences at the University of Montpellier, where he earned his PharmD from 1979 to 1985. This foundational education provided him with a comprehensive understanding of drug development and healthcare practices. Additionally, he holds a PhD, further enhancing his expertise in the field.
Leadership Roles in Healthcare Organizations
Throughout his career, Bruno Strigini has held various leadership positions in prominent healthcare organizations. He served as President at Merck & Co. and held multiple executive roles at Schering-Plough, UCB Celltech, and SmithKline Beecham. His experience includes overseeing international operations and global marketing, contributing to his extensive knowledge of the healthcare landscape.
Advisory Role at Permira
Since 2020, Bruno Strigini has been a Senior Advisor at Permira, a global investment firm. In this capacity, he provides strategic guidance and insights based on his extensive experience in the healthcare sector. His role involves advising on investments and opportunities within the industry, leveraging his background to support the firm's objectives in London, United Kingdom.